Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

7 Biggest Lithium-mining Companies in 2024

Uranium Stocks: 5 Biggest Companies in 2024

Top 10 Oil-producing Countries (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies in 2024

10 Largest Producers of Gold by Country (Updated 2024)

What Was the Highest Price for Gold? (Updated 2024)

Top 10 Copper-producing Companies (Updated 2024)

Trending Press Releases

Heritage Mining Announces Partnership with Altitude Capital Consultants Inc. and Non-Brokered Private Placement

Outstanding Drill Results Confirm High Grade Uranium Mineralisation at the Ashburton Project

World Class Copper Potential Increased at Yataga Copper Project – Georgetown, QLD

SAGA Metals Completes IPO with Focus on Uranium Exploration and Rio Tinto Partnership

Saga Metals: Diversified Portfolio of Critical Mineral Assets in Canada’s Top-tier Jurisdictions

More Press Releases
Trending Companies

Element79 Gold Corp

ELEM:CC

Brunswick Exploration

BRW:TCM

Black Swan Graphene

SWAN:CC

Sirona Biochem

SBM:CA
More Companies
Trending Reports

2024 Copper Outlook Report

2024 Lithium Market Outlook

2024 Gold Outlook Report

Silver Price Forecast - What Happened And Where Do We Go From Here?

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

NRX Pharmaceuticals Inc.

NASDAQ:NRXP
Press Releases

NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Interactive Chart

×